SBC Medical Group Holdings Q2 2025 Earnings: Revenue Down 18%, Net Income Down 87%

SBC Medical Group Holdings reported Q2 2025 earnings with revenue down 18% to $43.4m, net income down 87% to $2.46m, and EPS down to $0.024. The profit margin decreased to 5.7% due to lower revenue. The company forecasts a 1.2% p.a. revenue growth average over the next 2 years, compared to a 6.0% growth forecast for the US Healthcare industry.

SBC Medical Group Holdings Incorporated (SBC Medical) reported its Q2 2025 earnings, revealing a significant decline in revenue and earnings per share (EPS), though net income remained high. The company's revenue decreased by 18.3% to $43.36 million, while EPS dropped 90.0% to $0.02 [1]. Net income, however, was the highest in the past two years at $2.44 million, a 86.9% reduction from the previous year [1].

The company attributed the decline in revenue to strategic shifts, including staffing service closures, fee structure revisions, and the acquisition of MB Career Lounge [1]. Despite the challenging quarter, SBC Medical's stock prices rose 5.24% post-earnings, but fell 13.7% monthly, reflecting mixed investor sentiment [1].

SBC Medical's CEO, Yoshiyuki Aikawa, emphasized that the company is focusing on long-term competitiveness through strategic positioning and franchise optimization [1]. The company also announced plans to transition to higher-margin business models and capture growth opportunities. However, it did not provide specific financial guidance for future periods.

SBC Medical's revenue growth forecast for the next two years is 1.2% per annum, which is lower than the 6.0% growth forecast for the US Healthcare industry [1]. This discrepancy highlights the company's focus on strategic shifts rather than immediate revenue growth.

References:
[1] https://www.ainvest.com/news/sbc-medical-group-2025-q2-earnings-sharp-eps-drop-record-net-income-2508/